Your trusted destination for CME, CPD & Medical Education across the Middle East.
Syndicate Bio
Dr. Abasi Ene-Obong is a Nigerian biomedical scientist, biotechnology entrepreneur, and business executive recognized for his contributions to genomics, precision medicine, biotechnology, and healthcare innovation. He is the Founder and Chief Executive Officer of Syndicate Bio, a biotechnology company focused on developing diverse human health datasets and applying artificial intelligence and machine learning to biomedical research and precision medicine.
Dr. Ene-Obong began his academic journey at the University of Calabar in Nigeria, where he obtained a Bachelor's degree in Genetics and Biotechnology. He subsequently pursued postgraduate studies at Imperial College London, earning a Master's degree in Human Molecular Genetics. He later completed a PhD in Cancer Biology at the University of London, through Barts and The London School of Medicine and Dentistry. He also obtained a Master's degree in Bioscience Management from the Keck Graduate Institute in California, United States.
Before establishing his biotechnology companies, Dr. Ene-Obong worked as a cancer researcher in the United Kingdom, contributing to scientific research in cancer biology and pancreatic cancer immunology. His research has been published in respected scientific journals, including Gastroenterology, Nature, Cell, and Cancer Discovery. He subsequently developed professional experience in healthcare consulting, working with international organizations such as PwC and IQVIA, advising pharmaceutical companies, academic institutions, and healthcare organizations on business strategy and healthcare development.
In 2019, he founded 54gene, an African genomics and health technology company established to address the underrepresentation of African populations in global genetic research. As its Chief Executive Officer, he led the development of a large-scale African genomic biobank containing more than 100,000 samples connected to clinical records. The initiative aimed to strengthen African participation in global biomedical discovery, drug development, and precision medicine.
Following his departure from 54gene's leadership, Dr. Ene-Obong established Syndicate Bio in 2023. Through this venture, he continues to advance genomic research, artificial intelligence, and precision healthcare by developing more representative human health datasets. His work emphasizes the importance of including genetically diverse populations in biomedical research to improve disease understanding and healthcare outcomes worldwide.

dmg events
dmg events